ID   HeLa
AC   CVCL_0030
SY   HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri
DR   BTO; BTO:0000567
DR   CLO; CLO_0003684
DR   CLO; CLO_0050910
DR   EFO; EFO_0001185
DR   MCCL; MCC:0000219
DR   CLDB; cl1594
DR   CLDB; cl1595
DR   CLDB; cl1596
DR   CLDB; cl1597
DR   CLDB; cl1599
DR   CLDB; cl1600
DR   CLDB; cl1601
DR   CLDB; cl1603
DR   Abcam; ab255448
DR   Abcam; ab255928
DR   Abcam; ab260075
DR   Abcam; ab271142
DR   Abcam; ab275466
DR   AddexBio; C0008001/44
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-2
DR   ATCC; CRM-CCL-2
DR   ATCC; CRL-7923
DR   BCRC; 60005
DR   BCRJ; 0100
DR   BioGRID_ORCS_Cell_line; 95
DR   BioSample; SAMN03471148
DR   BioSample; SAMN03472333
DR   BioSample; SAMN10989629
DR   cancercelllines; CVCL_0030
DR   CCLV; CCLV-RIE 0082
DR   CCRID; 1101HUM-PUMC000011
DR   CCRID; 1101HUM-PUMC000332
DR   CCRID; 1102HUM-NIFDC00057
DR   CCRID; 3101HUMSCSP504
DR   CCRID; 3101HUMTCHu187
DR   CCRID; 4201HUM-CCTCC00009
DR   CCRID; 5301HUM-KCB90024YJ
DR   CCTCC; GDC0009
DR   Cell_Model_Passport; SIDM00846
DR   ChEMBL-Cells; CHEMBL3308376
DR   ChEMBL-Targets; CHEMBL399
DR   CLS; 300194
DR   Cosmic; 760219
DR   Cosmic; 760490
DR   Cosmic; 801357
DR   Cosmic; 809231
DR   Cosmic; 877477
DR   Cosmic; 911999
DR   Cosmic; 925354
DR   Cosmic; 928907
DR   Cosmic; 944113
DR   Cosmic; 1019309
DR   Cosmic; 1057766
DR   Cosmic; 1071911
DR   Cosmic; 1131525
DR   Cosmic; 1193029
DR   Cosmic; 1201779
DR   Cosmic; 1324208
DR   Cosmic; 1336880
DR   Cosmic; 1571796
DR   Cosmic; 2301539
DR   Cosmic; 2660190
DR   Cosmic; 2750874
DR   Cosmic; 2791019
DR   Cosmic; 2816214
DR   Cosmic-CLP; 1298134
DR   DepMap; ACH-001086
DR   DSMZ; ACC-57
DR   DSMZCellDive; ACC-57
DR   ECACC; 93021013
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; phs000640
DR   FCS-free; 44-2-47-1-8-9
DR   GDSC; 1298134
DR   GEO; GSM113863
DR   GEO; GSM226739
DR   GEO; GSM226875
DR   GEO; GSM253298
DR   GEO; GSM436128
DR   GEO; GSM436129
DR   GEO; GSM501788
DR   GEO; GSM722574
DR   GEO; GSM722575
DR   GEO; GSM723055
DR   GEO; GSM723056
DR   GEO; GSM1088663
DR   GEO; GSM1088664
DR   GEO; GSM1088665
DR   GEO; GSM1088666
DR   GEO; GSM1374528
DR   GEO; GSM1669875
DR   GEO; GSM1881473
DR   GEO; GSM1881474
DR   GEO; GSM1881475
DR   HIVReagentProgram; ARP-153
DR   ICLC; HTL95023
DR   IGRhCellID; HeLA
DR   IZSLER; BS TCL 20
DR   JCRB; JCRB9004
DR   KCB; KCB 86019YJ
DR   KCB; KCB 90024YJ
DR   KCLB; 10002
DR   LINCS_HMS; 50061
DR   LINCS_LDP; LCL-1512
DR   Lonza; 51
DR   MeSH; D006367
DR   NCBI_Iran; C115
DR   PharmacoDB; HeLa_536_2019
DR   PRIDE; PRD000007
DR   PRIDE; PRD000032
DR   PRIDE; PRD000123
DR   PRIDE; PRD000124
DR   PRIDE; PRD000345
DR   PRIDE; PRD000376
DR   PRIDE; PRD000525
DR   PRIDE; PRD000526
DR   PRIDE; PRD000527
DR   PRIDE; PXD000013
DR   PRIDE; PXD000243
DR   PRIDE; PXD000252
DR   PRIDE; PXD000279
DR   PRIDE; PXD000396
DR   PRIDE; PXD000474
DR   PRIDE; PXD000589
DR   PRIDE; PXD000661
DR   PRIDE; PXD000680
DR   PRIDE; PXD000759
DR   PRIDE; PXD000883
DR   PRIDE; PXD000895
DR   PRIDE; PXD000900
DR   PRIDE; PXD000953
DR   PRIDE; PXD000954
DR   PRIDE; PXD000999
DR   PRIDE; PXD001047
DR   PRIDE; PXD001118
DR   PRIDE; PXD001154
DR   PRIDE; PXD001175
DR   PRIDE; PXD001249
DR   PRIDE; PXD001258
DR   PRIDE; PXD001259
DR   PRIDE; PXD001278
DR   PRIDE; PXD001305
DR   PRIDE; PXD001374
DR   PRIDE; PXD001381
DR   PRIDE; PXD001396
DR   PRIDE; PXD001441
DR   PRIDE; PXD001541
DR   PRIDE; PXD001548
DR   PRIDE; PXD001574
DR   PRIDE; PXD001660
DR   PRIDE; PXD001781
DR   PRIDE; PXD001798
DR   PRIDE; PXD001805
DR   PRIDE; PXD001806
DR   PRIDE; PXD001810
DR   PRIDE; PXD001863
DR   PRIDE; PXD001907
DR   PRIDE; PXD002001
DR   PRIDE; PXD002039
DR   PRIDE; PXD002066
DR   PRIDE; PXD002252
DR   PRIDE; PXD002277
DR   PRIDE; PXD002378
DR   PRIDE; PXD002383
DR   PRIDE; PXD002395
DR   PRIDE; PXD002572
DR   PRIDE; PXD002591
DR   PRIDE; PXD002704
DR   PRIDE; PXD002844
DR   PRIDE; PXD002880
DR   PRIDE; PXD003186
DR   PRIDE; PXD003209
DR   PRIDE; PXD003258
DR   PRIDE; PXD003370
DR   PRIDE; PXD003503
DR   PRIDE; PXD003530
DR   PRIDE; PXD003560
DR   PRIDE; PXD003792
DR   PRIDE; PXD003813
DR   PRIDE; PXD003909
DR   PRIDE; PXD003913
DR   PRIDE; PXD003917
DR   PRIDE; PXD003924
DR   PRIDE; PXD004182
DR   PRIDE; PXD004271
DR   PRIDE; PXD004273
DR   PRIDE; PXD004452
DR   PRIDE; PXD004613
DR   PRIDE; PXD004736
DR   PRIDE; PXD004900
DR   PRIDE; PXD004914
DR   PRIDE; PXD004933
DR   PRIDE; PXD004934
DR   PRIDE; PXD004940
DR   PRIDE; PXD004995
DR   PRIDE; PXD005018
DR   PRIDE; PXD005107
DR   PRIDE; PXD005181
DR   PRIDE; PXD005346
DR   PRIDE; PXD005349
DR   PRIDE; PXD005366
DR   PRIDE; PXD005466
DR   PRIDE; PXD005509
DR   PRIDE; PXD005572
DR   PRIDE; PXD005712
DR   PRIDE; PXD005955
DR   PRIDE; PXD006112
DR   PRIDE; PXD006293
DR   PRIDE; PXD012045
DR   PRIDE; PXD012188
DR   PRIDE; PXD013064
DR   PRIDE; PXD023271
DR   PRIDE; PXD023835
DR   PRIDE; PXD027504
DR   PRIDE; PXD029773
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0030
DR   PubChem_Cell_line; CVCL_0030
DR   RCB; RCB0007
DR   RCB; RCB3680
DR   SKY/M-FISH/CGH; 5351
DR   TKG; TKG 0331
DR   TOKU-E; 1434
DR   Ubigene; YC-A012
DR   Wikidata; Q847482
RX   CelloPub=CLPUB00047;
RX   CelloPub=CLPUB00262;
RX   CelloPub=CLPUB00376;
RX   CelloPub=CLPUB00377;
RX   CelloPub=CLPUB00468;
RX   CelloPub=CLPUB00507;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=77569;
RX   PubMed=1246620;
RX   PubMed=1522048;
RX   PubMed=2983228;
RX   PubMed=2990217;
RX   PubMed=3028716;
RX   PubMed=3180844;
RX   PubMed=3371749;
RX   PubMed=3518877;
RX   PubMed=4942173;
RX   PubMed=5668122;
RX   PubMed=6256643;
RX   PubMed=6358339;
RX   PubMed=6401685;
RX   PubMed=6825208;
RX   PubMed=6935474;
RX   PubMed=8380785;
RX   PubMed=9892199;
RX   PubMed=10423141;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12001993;
RX   PubMed=12661003;
RX   PubMed=12793746;
RX   PubMed=13052828;
RX   PubMed=13207312;
RX   PubMed=13261081;
RX   PubMed=14031339;
RX   PubMed=14185313;
RX   PubMed=15302935;
RX   PubMed=15531914;
RX   PubMed=15901131;
RX   PubMed=16589695;
RX   PubMed=17311676;
RX   PubMed=19450234;
RX   PubMed=19722756;
RX   PubMed=19941903;
RX   PubMed=21269460;
RX   PubMed=21937730;
RX   PubMed=22068331;
RX   PubMed=22278370;
RX   PubMed=22412903;
RX   PubMed=23205564;
RX   PubMed=23336012;
RX   PubMed=23925224;
RX   PubMed=23925245;
RX   PubMed=24134916;
RX   PubMed=24618588;
RX   PubMed=24696503;
RX   PubMed=24908793;
RX   PubMed=25485619;
RX   PubMed=25807930;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=26554430;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28078501;
RX   PubMed=28196595;
RX   PubMed=28261610;
RX   PubMed=28601559;
RX   PubMed=29156801;
RX   PubMed=30175587;
RX   PubMed=30778230;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31433507;
RX   PubMed=31790455;
RX   PubMed=33389257;
RX   PubMed=35198691;
RX   PubMed=35839778;
RX   PubMed=37543987;
WW   https://en.wikipedia.org/wiki/HeLa
WW   https://www.tebu-bio.com/blog/2017/11/28/hela-cells-the-first-cell-line/
WW   https://www.proteinatlas.org/learn/cellines
WW   http://141.61.102.20/mxdb/project/show/9191407937500
WW   https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hela/helacells.html
WW   https://www.olympus-lifescience.com/de/microscope-resource/primer/techniques/fluorescence/gallery/cells/epithelialindex/
WW   http://www.lacksfamily.net/
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-35.html
WW   https://www.cynthiaverspaget.com/the-anarchy-cell-line
WW   http://genomesunzipped.org/2013/03/henrietta-lackss-genome-sequence-has-been-publicly-available-for-years.php
WW   https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000640.v4.p1
WW   https://tcpaportal.org/mclp/
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22)(q24;q13).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 1.3 days (PubMed=29156801); ~48 hours (DSMZ=ACC-57).
CC   HLA typing: A*03,28; B*w15,w35; C*w02,w03 (PubMed=77569).
CC   HLA typing: A*03:19,68:02; B*15:03,15:03; C*12:03,12:03; DRB1*01:02,01:02 (PubMed=25960936).
CC   HLA typing: A*68:02,68:02; B*15:03,15:03; C*12:03,12:03; DQA1*01:02,01:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Cell surface proteome.
CC   Omics: CNV analysis.
CC   Omics: Deep antibody staining analysis.
CC   Omics: Deep exome analysis.
CC   Omics: Deep membrane proteome analysis.
CC   Omics: Deep phosphoproteome analysis.
CC   Omics: Deep proteome analysis.
CC   Omics: Deep quantitative proteome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: Genome sequenced.
CC   Omics: Glycoproteome analysis by proteomics.
CC   Omics: Myristoylated proteins analysis by proteomics.
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Omics: scRNAseq analysis.
CC   Omics: Secretome proteome analysis by 2D-DE/MS.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Omics: Virome analysis using proteomics.
CC   Genome ancestry: African=64.74%; Native American=0.77%; East Asian, North=2.26%; East Asian, South=0%; South Asian=0%; European, North=19.45%; European, South=12.78% (PubMed=30894373).
CC   Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line.
CC   Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377).
CC   Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line.
CC   Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89.
CC   Miscellaneous: HeLa is the most frequent contributor to cell lines contamination.
CC   Discontinued: ATCC; CRL-7923; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; DSMZ; ECACC; Genomics_Center_BCF_Technion; JCRB; KCLB; PubMed=11416159; PubMed=25877200; PubMed=29156801; PubMed=37543987; RCB; TKG
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D10S1248: 13,15
ST   D12S391: 20,25
ST   D13S317: 12 (Cosmic-CLP; RCB)
ST   D13S317: 12,13.3 (AddexBio; ATCC; CCRID; DSMZ; Genomics_Center_BCF_Technion; JCRB; KCLB; PubMed=25877200; PubMed=29156801; PubMed=37543987; TKG)
ST   D13S317: 12,14 (ECACC)
ST   D13S317: 13,13.3 (CLS)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D1S1656: 12,15
ST   D21S11: 27 (CLS)
ST   D21S11: 27,28 (CCRID; DSMZ; Genomics_Center_BCF_Technion; PubMed=25877200; PubMed=37543987)
ST   D22S1045: 16,17
ST   D2S1338: 17
ST   D2S441: 10,11
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8 (CLS)
ST   Penta D: 8,15 (CCRID; DSMZ; Genomics_Center_BCF_Technion; PubMed=25877200; PubMed=37543987)
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 46
//
RX   CelloPub=CLPUB00047;
RA   Gey G.O., Coffman W.D., Kubicek M.T.;
RT   "Tissue culture studies of the proliferative capacity of cervical
RT   carcinoma and normal epithelium.";
RL   Cancer Res. 12:264-265(1952).
//
RX   CelloPub=CLPUB00262;
RA   Gold M.;
RT   "A conspiracy of cells. One woman's immortal legacy and the medical
RT   scandal it caused.";
RL   (In) ISBN 9780887060991; pp.1-171; State University of New York Press; Albany (1986).
//
RX   CelloPub=CLPUB00376;
RA   Verspaget C.J.;
RT   "Unruly bodies: monstrous readings of biotechnology.";
RL   Thesis PhD (2015), Curtin University, Australia.
//
RX   CelloPub=CLPUB00377;
RA   Skloot R.L.;
RT   "The immortal life of Henrietta Lacks.";
RL   (In) ISBN 9781400052172; pp.1-400; Random House; New York (2010).
//
RX   CelloPub=CLPUB00468;
RA   Javitt G.H.;
RT   "Why not take all of me? Reflections on the immortal life of Henrietta
RT   Lacks and the status of participants in research using human
RT   specimens.";
RL   Minn. J. Law Sci. Technol. 11:713-755(2010).
//
RX   CelloPub=CLPUB00507;
RA   Pultarova T.;
RT   "HeLa cells: immortal space travellers.";
RL   Space Saf. Mag. 7:10-12(2013).
//
RX   DOI=10.1007/978-1-4757-1647-4_13;
RA   Biedler J.L.;
RT   "Chromosome abnormalities in human tumor cells in culture.";
RL   (In) Human tumor cells in vitro; Fogh J. (eds.); pp.359-394; Springer; New York (1975).
//
RX   DOI=10.1007/BF02618370;
RA   Stulberg C.S., Coriell L.L., Kniazeff A.J., Shannon J.E.;
RT   "The animal cell culture collection.";
RL   In Vitro 5:1-16(1970).
//
RX   PubMed=77569; DOI=10.1111/j.1399-0039.1978.tb01259.x;
RA   Espmark J.A., Ahlqvist-Roth L., Sarne L., Persson A.;
RT   "Tissue typing of cells in culture. III. HLA antigens of established
RT   human cell lines. Attempts at typing by the mixed hemadsorption
RT   technique.";
RL   Tissue Antigens 11:279-286(1978).
//
RX   PubMed=1246620; DOI=10.1126/science.1246620;
RA   Hsu S.H., Schacter B.Z., Delaney N.L., Miller T.B., McKusick V.A.,
RA   Kennett R.H., Bodmer J.G., Young D., Bodmer W.F.;
RT   "Genetic characteristics of the HeLa cell.";
RL   Science 191:392-394(1976).
//
RX   PubMed=1522048; DOI=10.1007/BF02634140;
RA   Kataoka E., Honma M., Ohnishi K., Sofuni T., Mizusawa H.;
RT   "Application of highly polymorphic DNA markers to the identification
RT   of HeLa cell sublines.";
RL   In Vitro Cell. Dev. Biol. Anim. 28:553-556(1992).
//
RX   PubMed=2983228; DOI=10.1038/314111a0;
RA   Schwarz E., Freese U.-K., Gissmann L., Mayer W., Roggenbuck B.,
RA   Stremlau A., zur Hausen H.;
RT   "Structure and transcription of human papillomavirus sequences in
RT   cervical carcinoma cells.";
RL   Nature 314:111-114(1985).
//
RX   PubMed=2990217;
RA   Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M.;
RT   "Presence and expression of human papillomavirus sequences in human
RT   cervical carcinoma cell lines.";
RL   Am. J. Pathol. 119:361-366(1985).
//
RX   PubMed=3028716; DOI=10.1159/000132342;
RA   Popescu N.C., DiPaolo J.A., Amsbaugh S.C.;
RT   "Integration sites of human papillomavirus 18 DNA sequences on HeLa
RT   cell chromosomes.";
RL   Cytogenet. Cell Genet. 44:58-62(1987).
//
RX   PubMed=3180844; DOI=10.1159/000132579;
RA   Chen T.-R.;
RT   "Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes.";
RL   Cytogenet. Cell Genet. 48:19-24(1988).
//
RX   PubMed=3371749; DOI=10.1016/0090-8258(88)90029-7;
RA   Grenman S.E., Shapira A., Carey T.E.;
RT   "In vitro response of cervical cancer cell lines CaSki, HeLa, and
RT   ME-180 to the antiestrogen tamoxifen.";
RL   Gynecol. Oncol. 30:228-238(1988).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=4942173; DOI=10.1097/00006250-197112000-00028;
RA   Jones H.W. Jr., McKusick V.A., Harper P.S., Wuu K.-D.;
RT   "George Otto Gey (1899-1970). The HeLa cell and a reappraisal of its
RT   origin.";
RL   Obstet. Gynecol. 38:945-949(1971).
//
RX   PubMed=5668122; DOI=10.3181/00379727-128-33119;
RA   Peterson W.D. Jr., Stulberg C.S., Swanborg N.K., Robinson A.R.;
RT   "Glucose-6-phosphate dehydrogenase isoenzymes in human cell cultures
RT   determined by sucrose-agar gel and cellulose acetate zymograms.";
RL   Proc. Soc. Exp. Biol. Med. 128:772-776(1968).
//
RX   PubMed=6256643; DOI=10.1038/288724a0;
RA   Day R.S. III, Ziolkowski C.H.J., Scudiero D.A., Meyer S.A.,
RA   Lubiniecki A.S., Girardi A.J., Galloway S.M., Bynum G.D.;
RT   "Defective repair of alkylated DNA by human tumour and
RT   SV40-transformed human cell strains.";
RL   Nature 288:724-727(1980).
//
RX   PubMed=6358339; DOI=10.1093/jhmas/38.4.415;
RA   Brown R.W., Henderson J.H.M.;
RT   "The mass production and distribution of HeLa cells at Tuskegee
RT   Institute, 1953-55.";
RL   J. Hist. Med. Allied Sci. 38:415-431(1983).
//
RX   PubMed=6401685; DOI=10.1007/BF02617989;
RA   Halton D.M., Peterson W.D. Jr., Hukku B.;
RT   "Cell culture quality control by rapid isoenzymatic
RT   characterization.";
RL   In Vitro 19:16-24(1983).
//
RX   PubMed=6825208; DOI=10.1093/carcin/4.2.199;
RA   Yarosh D.B., Foote R.S., Mitra S., Day R.S. III;
RT   "Repair of O6-methylguanine in DNA by demethylation is lacking in Mer-
RT   human tumor cell strains.";
RL   Carcinogenesis 4:199-205(1983).
//
RX   PubMed=6935474; DOI=10.1093/jnci/66.2.239;
RA   Wright W.C., Daniels W.P., Fogh J.;
RT   "Distinction of seventy-one cultured human tumor cell lines by
RT   polymorphic enzyme analysis.";
RL   J. Natl. Cancer Inst. 66:239-247(1981).
//
RX   PubMed=8380785; DOI=10.1006/gyno.1993.1016;
RA   Iwasaka T., Oh-uchida M., Matsuo N., Yokoyama M., Fukuda K., Hara K.,
RA   Fukuyama K., Hori K., Sugimori H.;
RT   "Correlation between HPV positivity and state of the p53 gene in
RT   cervical carcinoma cell lines.";
RL   Gynecol. Oncol. 48:104-109(1993).
//
RX   PubMed=9892199;
RA   Macville M.V.E., Schrock E., Padilla-Nash H.M., Keck C., Ghadimi B.M.,
RA   Zimonjic D.B., Popescu N.C., Ried T.;
RT   "Comprehensive and definitive molecular cytogenetic characterization
RT   of HeLa cells by spectral karyotyping.";
RL   Cancer Res. 59:141-150(1999).
//
RX   PubMed=10423141; DOI=10.1099/0022-1317-80-7-1725;
RA   Meissner J.D.;
RT   "Nucleotide sequences and further characterization of human
RT   papillomavirus DNA present in the CaSki, SiHa and HeLa cervical
RT   carcinoma cell lines.";
RL   J. Gen. Virol. 80:1725-1733(1999).
//
RX   PubMed=11416159; DOI=10.1073/pnas.121616198;
RA   Masters J.R.W., Thomson J.A., Daly-Burns B., Reid Y.A., Dirks W.G.,
RA   Packer P., Toji L.H., Ohno T., Tanabe H., Arlett C.F., Kelland L.R.,
RA   Harrison M., Virmani A.K., Ward T.H., Ayres K.L., Debenham P.G.;
RT   "Short tandem repeat profiling provides an international reference
RT   standard for human cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001).
//
RX   PubMed=11668190; DOI=10.1177/002215540104901105;
RA   Quentmeier H., Osborn M., Reinhardt J., Zaborski M., Drexler H.G.;
RT   "Immunocytochemical analysis of cell lines derived from solid
RT   tumors.";
RL   J. Histochem. Cytochem. 49:1369-1378(2001).
//
RX   PubMed=12001993; DOI=10.1038/nrc775;
RA   Masters J.R.W.;
RT   "HeLa cells 50 years on: the good, the bad and the ugly.";
RL   Nat. Rev. Cancer 2:315-319(2002).
//
RX   PubMed=12661003; DOI=10.1002/gcc.10196;
RA   Seitz S., Wassmuth P., Plaschke J., Schackert H.K., Karsten U.,
RA   Santibanez-Koref M.F., Schlag P.M., Scherneck S.;
RT   "Identification of microsatellite instability and mismatch repair gene
RT   mutations in breast cancer cell lines.";
RL   Genes Chromosomes Cancer 37:29-35(2003).
//
RX   PubMed=12793746; DOI=10.1269/jrr.43.s133;
RA   Ohnishi T., Ohnishi K., Takahashi A., Taniguchi Y., Sato M.,
RA   Nakano T., Nagaoka S.;
RT   "Detection of DNA damage induced by space radiation in Mir and space
RT   shuttle.";
RL   J. Radiat. Res. 43:S133-S136(2002).
//
RX   PubMed=13052828; DOI=10.1084/jem.97.5.695;
RA   Scherer W.F., Syverton J.T., Gey G.O.;
RT   "Studies on the propagation in vitro of poliomyelitis viruses. IV.
RT   Viral multiplication in a stable strain of human malignant epithelial
RT   cells (strain HeLa) derived from an epidermoid carcinoma of the
RT   cervix.";
RL   J. Exp. Med. 97:695-710(1953).
//
RX   PubMed=13207312;
RA   Scherer W.F., Syverton J.T.;
RT   "The viral range in vitro of a malignant human epithelial cell (strain
RT   HeLa, Gey). I. Multiplication of herpes simplex, pseudorabies, and
RT   vaccinia viruses.";
RL   Am. J. Pathol. 30:1057-1073(1954).
//
RX   PubMed=13261081;
RA   Moore A.E., Sabachewsky L., Toolan H.W.;
RT   "Culture characteristics of four permanent lines of human cancer
RT   cells.";
RL   Cancer Res. 15:598-602(1955).
//
RX   PubMed=14031339;
RA   Katzberg A.A.;
RT   "The effect of space flights on living human cells aboard Discoverer
RT   XVIII.";
RL   Tech. Doc. Rep. SAMTDR USAF Sch. Aerosp. Med. 62:43.1-43.4(1962).
//
RX   PubMed=14185313; DOI=10.1126/science.146.3641.241;
RG   Cell Culture Collection Committee;
RT   "Animal cell strains. The Cell Culture Collection Committee has
RT   assembled and certified 23 strains of animal cells.";
RL   Science 146:241-243(1964).
//
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M.P., Schwartz D., Elias J.E., Villen J.,
RA   Li J.-X., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
//
RX   PubMed=15531914; DOI=10.1038/sj.onc.1208235;
RA   Baldus S.E., Schwarz E., Lohrey C., Zapatka M., Landsberg S.,
RA   Hahn S.A., Schmidt D., Dienes H.-P., Schmiegel W.H.,
RA   Schwarte-Waldhoff I.;
RT   "Smad4 deficiency in cervical carcinoma cells.";
RL   Oncogene 24:810-819(2005).
//
RX   PubMed=15901131; DOI=10.1016/j.prp.2005.01.002;
RA   Murai Y., Hayashi S., Takahashi H., Tsuneyama K., Takano Y.;
RT   "Correlation between DNA alterations and p53 and p16 protein
RT   expression in cancer cell lines.";
RL   Pathol. Res. Pract. 201:109-115(2005).
//
RX   PubMed=16589695; DOI=10.1073/pnas.41.7.432;
RA   Puck T.T., Marcus P.I.;
RT   "A rapid method for viable cell titration and clone production with
RT   HeLa cells in tissue culture: the use of X-irradiated cells to supply
RT   conditioning factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 41:432-437(1955).
//
RX   PubMed=17311676; DOI=10.1186/1471-2164-8-53;
RA   Kloth J.N., Oosting J., van Wezel T., Szuhai K., Knijnenburg J.,
RA   Gorter A., Kenter G.G., Fleuren G.J., Jordanova E.S.;
RT   "Combined array-comparative genomic hybridization and
RT   single-nucleotide polymorphism-loss of heterozygosity analysis reveals
RT   complex genetic alterations in cervical cancer.";
RL   BMC Genomics 8:53.1-53.13(2007).
//
RX   PubMed=19450234; DOI=10.2144/000113089;
RA   Rahbari R., Sheahan T., Modes V., Collier P., Macfarlane C.M.,
RA   Badge R.M.;
RT   "A novel L1 retrotransposon marker for HeLa cell line
RT   identification.";
RL   BioTechniques 46:277-284(2009).
//
RX   PubMed=19722756; DOI=10.5858/133.9.1463;
RA   Lucey B.P., Nelson-Rees W.A., Hutchins G.M.;
RT   "Henrietta Lacks, HeLa cells, and cell culture contamination.";
RL   Arch. Pathol. Lab. Med. 133:1463-1467(2009).
//
RX   PubMed=19941903; DOI=10.1016/j.jviromet.2009.11.022;
RA   Karger A., Bettin B., Lenk M., Mettenleiter T.C.;
RT   "Rapid characterisation of cell cultures by matrix-assisted laser
RT   desorption/ionisation mass spectrometric typing.";
RL   J. Virol. Methods 164:116-121(2010).
//
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17.1-17.13(2011).
//
RX   PubMed=21937730; DOI=10.1074/mcp.M111.011429;
RA   Boisvert F.-M., Ahmad Y., Gierlinski M., Charriere F., Lamont D.,
RA   Scott M., Barton G., Lamond A.I.;
RT   "A quantitative spatial proteomics analysis of proteome turnover in
RT   human cells.";
RL   Mol. Cell. Proteomics 11:M111.011429-M111.011429(2012).
//
RX   PubMed=22068331; DOI=10.1038/msb.2011.81;
RA   Nagaraj N., Wisniewski J.R., Geiger T., Cox J., Kircher M., Kelso J.,
RA   Paabo S., Mann M.;
RT   "Deep proteome and transcriptome mapping of a human cancer cell
RT   line.";
RL   Mol. Syst. Biol. 7:548-548(2011).
//
RX   PubMed=22278370; DOI=10.1074/mcp.M111.014050;
RA   Geiger T., Wehner A., Schaab C., Cox J., Mann M.;
RT   "Comparative proteomic analysis of eleven common cell lines reveals
RT   ubiquitous but varying expression of most proteins.";
RL   Mol. Cell. Proteomics 11:M111.014050-M111.014050(2012).
//
RX   PubMed=22412903; DOI=10.1371/journal.pone.0032667;
RA   Vazquez-Mena O., Medina-Martinez I., Juarez-Torres E., Barron V.,
RA   Espinosa A., Villegas-Sepulveda N., Gomez-Laguna L.,
RA   Nieto-Martinez K., Orozco L., Roman-Bassaure E., Munoz Cortez S.,
RA   Borges Ibanez M., Venegas-Vega C.A., Guardado-Estrada M.,
RA   Rangel-Lopez A., Kofman S., Berumen J.;
RT   "Amplified genes may be overexpressed, unchanged, or downregulated in
RT   cervical cancer cell lines.";
RL   PLoS ONE 7:E32667-E32667(2012).
//
RX   PubMed=23205564; DOI=10.1021/pr300859k;
RA   Malerod H., Graham R.L.J., Sweredoski M.J., Hess S.;
RT   "Comprehensive profiling of N-linked glycosylation sites in HeLa cells
RT   using hydrazide enrichment.";
RL   J. Proteome Res. 12:248-259(2013).
//
RX   PubMed=23336012; DOI=10.1371/journal.pone.0054672;
RA   Horvat T., Dezeljin M., Redzic I., Barisic D., Herak Bosnar M.,
RA   Lauc G., Zoldos V.;
RT   "Reversibility of membrane N-glycome of HeLa cells upon treatment with
RT   epigenetic inhibitors.";
RL   PLoS ONE 8:E54672-E54672(2013).
//
RX   PubMed=23925224; DOI=10.1038/500141a;
RA   Hudson K.L., Collins F.S.;
RT   "Biospecimen policy: family matters.";
RL   Nature 500:141-142(2013).
//
RX   PubMed=23925245; DOI=10.1038/nature12064;
RA   Adey A., Burton J.N., Kitzman J.O., Hiatt J.B., Lewis A.P.,
RA   Martin B.K., Qiu R.-L., Lee C., Shendure J.;
RT   "The haplotype-resolved genome and epigenome of the aneuploid HeLa
RT   cancer cell line.";
RL   Nature 500:207-211(2013).
//
RX   PubMed=24134916; DOI=10.1186/1755-8166-6-44;
RA   McCormack A., Fan J.-L., Duesberg M., Bloomfield M., Fiala C.,
RA   Duesberg P.H.;
RT   "Individual karyotypes at the origins of cervical carcinomas.";
RL   Mol. Cytogenet. 6:44.1-44.23(2013).
//
RX   PubMed=24618588; DOI=10.1371/journal.pone.0091433;
RA   Chernobrovkin A.L., Zubarev R.A.;
RT   "Detection of viral proteins in human cells lines by xeno-proteomics:
RT   elimination of the last valid excuse for not testing every cellular
RT   proteome dataset for viral proteins.";
RL   PLoS ONE 9:E91433-E91433(2014).
//
RX   PubMed=24696503; DOI=10.1074/mcp.M113.035170;
RA   Guo X.-F., Trudgian D.C., Lemoff A., Yadavalli S., Mirzaei H.;
RT   "Confetti: a multiprotease map of the HeLa proteome for comprehensive
RT   proteomics.";
RL   Mol. Cell. Proteomics 13:1573-1584(2014).
//
RX   PubMed=24908793;
RA   Gilgenkrantz S.;
RT   "Sixty years of HeLa cell cultures.";
RL   Hist. Sci. Med. 48:139-144(2014).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25807930; DOI=10.1002/anie.201500342;
RA   Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J.,
RA   Magee A.I., Tate E.W.;
RT   "Multifunctional reagents for quantitative proteome-wide analysis of
RT   protein modification in human cells and dynamic profiling of protein
RT   lipidation during vertebrate development.";
RL   Angew. Chem. Int. Ed. 54:5948-5951(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=25894527; DOI=10.1371/journal.pone.0121314;
RA   Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F.,
RA   Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R.,
RA   Schmidt A., Mirkowska P., Hartlova A.S., Van Eyk J.E., Bourquin J.-P.,
RA   Aebersold R., Boheler K.R., Zandstra P.W., Wollscheid B.;
RT   "A mass spectrometric-derived cell surface protein atlas.";
RL   PLoS ONE 10:E0121314-E0121314(2015).
//
RX   PubMed=25960936; DOI=10.4161/21624011.2014.954893;
RA   Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.;
RT   "A catalog of HLA type, HLA expression, and neo-epitope candidates in
RT   human cancer cell lines.";
RL   OncoImmunology 3:e954893.1-e954893.12(2014).
//
RX   PubMed=26554430; DOI=10.1021/acs.analchem.5b03639;
RA   Dimayacyac-Esleta B.R.T., Tsai C.-F., Kitata R.B., Lin P.-Y., Choong W.-K.,
RA   Lin T.-D., Wang Y.-T., Weng S.-H., Yang P.-C., Arco S.D., Sung T.-Y.,
RA   Chen Y.-J.;
RT   "Rapid high-pH reverse phase stagetip for sensitive small-scale
RT   membrane proteomic profiling.";
RL   Anal. Chem. 87:12016-12023(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S.,
RA   Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P.,
RA   Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H.,
RA   Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=28078501; DOI=10.1007/s11626-016-0128-8;
RA   Ambrose C.T.;
RT   "The Tissue Culture Laboratory of Dr. George Otto Gey 60 yrs ago as
RT   recalled by a former student.";
RL   In Vitro Cell. Dev. Biol. Anim. 53:467-473(2017).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005;
RA   Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P.,
RA   Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   PubMed=28261610; DOI=10.1155/2017/4180703;
RA   Kontostathi G., Zoidakis J., Makridakis M., Lygirou V., Mermelekas G.,
RA   Papadopoulos T., Vougas K., Vlamis-Gardikas A., Drakakis P.,
RA   Loutradis D., Vlahou A., Anagnou N.P., Pappa K.I.;
RT   "Cervical cancer cell line secretome highlights the roles of
RT   transforming growth factor-beta-induced protein ig-h3,
RT   peroxiredoxin-2, and NRF2 on cervical carcinogenesis.";
RL   Biomed Res. Int. 2017:4180703.1-4180703.15(2017).
//
RX   PubMed=28601559; DOI=10.1016/j.cels.2017.05.009;
RA   Bekker-Jensen D.B., Kelstrup C.D., Batth T.S., Larsen S.C.,
RA   Haldrup C., Bramsen J.B., Sorensen K.D., Hoyer S., Orntoft T.F.,
RA   Andersen C.L., Nielsen M.L., Olsen J.V.;
RT   "An optimized shotgun strategy for the rapid generation of
RT   comprehensive human proteomes.";
RL   Cell Syst. 4:587-599.e4(2017).
//
RX   PubMed=29156801; DOI=10.18632/oncotarget.21174;
RA   Kalu N.N., Mazumdar T., Peng S.-H., Shen L., Sambandam V., Rao X.-Y.,
RA   Xi Y.-X., Li L.-R., Qi Y., Gleber-Netto F.O., Patel A., Wang J.,
RA   Frederick M.J., Myers J.N., Pickering C.R., Johnson F.M.;
RT   "Genomic characterization of human papillomavirus-positive and
RT   -negative human squamous cell cancer cell lines.";
RL   Oncotarget 8:86369-86383(2017).
//
RX   PubMed=30175587; DOI=10.1021/acs.jproteome.8b00392;
RA   Robin T., Bairoch A., Muller M., Lisacek F., Lane L.;
RT   "Large-scale reanalysis of publicly available HeLa cell proteomics
RT   data in the context of the Human Proteome Project.";
RL   J. Proteome Res. 17:4160-4170(2018).
//
RX   PubMed=30778230; DOI=10.1038/s41587-019-0037-y;
RA   Liu Y.-S., Mi Y., Mueller T., Kreibich S., Williams E.G., Van Drogen A.,
RA   Borel C., Frank M., Germain P.-L., Bludau I., Mehnert M., Seifert M.,
RA   Emmenlauer M., Sorg I., Bezrukov F., Sloan-Bena F., Zhou H., Dehio C.,
RA   Testa G., Saez-Rodriguez J., Antonarakis S.E., Hardt W.-D.,
RA   Aebersold R.;
RT   "Multi-omic measurements of heterogeneity in HeLa cells across
RT   laboratories.";
RL   Nat. Biotechnol. 37:314-322(2019).
//
RX   PubMed=30787054; DOI=10.1158/1055-9965.EPI-18-1132;
RA   Hooker S.E. Jr., Woods-Burnham L., Bathina M., Lloyd S., Gorjala P.,
RA   Mitra R., Nonn L., Kimbro K.S., Kittles R.A.;
RT   "Genetic ancestry analysis reveals misclassification of commonly used
RT   cancer cell lines.";
RL   Cancer Epidemiol. Biomarkers Prev. 28:1003-1009(2019).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//
RX   PubMed=31433507; DOI=10.15252/embj.2018100847;
RA   Hardman G., Perkins S., Brownridge P.J., Clarke C.J., Byrne D.P.,
RA   Campbell A.E., Kalyuzhnyy A., Myall A., Eyers P.A., Jones A.R.,
RA   Eyers C.E.;
RT   "Strong anion exchange-mediated phosphoproteomics reveals extensive
RT   human non-canonical phosphorylation.";
RL   EMBO J. 38:e100847.1-e100847.22(2019).
//
RX   PubMed=31790455; DOI=10.1371/journal.pone.0225466;
RA   Hu W.-E., Zhang X., Guo Q.-F., Yang J.-W., Yang Y., Wei S.-C.,
RA   Su X.-D.;
RT   "HeLa-CCL2 cell heterogeneity studied by single-cell DNA and RNA
RT   sequencing.";
RL   PLoS ONE 14:E0225466-E0225466(2019).
//
RX   PubMed=33389257; DOI=10.1007/s10096-020-04106-0;
RA   Wurtz N., Penant G., Jardot P., Duclos N., La Scola B.;
RT   "Culture of SARS-CoV-2 in a panel of laboratory cell lines,
RT   permissivity, and differences in growth profile.";
RL   Eur. J. Clin. Microbiol. Infect. Dis. 40:477-484(2021).
//
RX   PubMed=35198691; DOI=10.1016/j.dib.2022.107919;
RA   Huang Z.-L., Kong W.-J., Wong B.J.-H., Gao H.-H., Guo T.-N., Liu X.-M.,
RA   Du X.-X., Wong L.-S., Goh W.W.-B.;
RT   "Proteomic datasets of HeLa and SiHa cell lines acquired by DDA-PASEF
RT   and diaPASEF.";
RL   Data Brief 41:107919.1-107919.7(2022).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010;
RA   Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N.,
RA   Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J.,
RA   Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L.,
RA   Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S.,
RA   Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B.,
RA   Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.;
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=37543987; DOI=10.1002/ijc.34677;
RA   Cao F., Sun H., Yang Z.-L., Bai Y.-H., Hu X., Hou Y.-H., Bian X.-C.,
RA   Liu Y.-Q.;
RT   "Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa
RT   cells rather than a gastric cancer cell line.";
RL   Int. J. Cancer 154:155-168(2023).
//